Vanguard Group’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,254,450
Closed -$639M 4631
2022
Q3
$639M Buy
23,254,450
+1,192,831
+5% +$29.6M 0.02% 702
2022
Q2
$509M Buy
22,061,619
+403,058
+2% +$9.41M 0.01% 845
2022
Q1
$472M Buy
21,658,561
+234,330
+1% +$4.87M 0.01% 1011
2021
Q4
$458M Sell
21,424,231
-891,082
-4% -$18.7M 0.01% 1058
2021
Q3
$467M Buy
22,315,313
+406,892
+2% +$8.88M 0.01% 1009
2021
Q2
$505M Buy
21,908,421
+1,573,952
+8% +$36.2M 0.01% 984
2021
Q1
$449M Buy
20,334,469
+431,300
+2% +$9.98M 0.01% 1021
2020
Q4
$371M Buy
19,903,169
+419,636
+2% +$6.9M 0.01% 1058
2020
Q3
$283M Sell
19,483,533
-1,135,344
-6% -$14.4M 0.01% 1044
2020
Q2
$231M Sell
20,618,877
-818,543
-4% -$9.19M 0.01% 1182
2020
Q1
$214M Buy
21,437,420
+16,977,804
+381% +$237M 0.01% 1090
2019
Q4
$73.1M Buy
4,459,616
+425,600
+11% +$5.71M ﹤0.01% 1924
2019
Q3
$48.7M Buy
4,034,016
+3,519,834
+685% +$48.3M ﹤0.01% 2080
2019
Q2
$7.51M Buy
+514,182
New +$7.61M ﹤0.01% 3017

Other funds holding CHNG

Vanguard Group's CHNG Position: Q4 2022 in Review

Vanguard Group sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 23,254,450 shares — an estimated $639M sold.

Vanguard Group first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $639M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Vanguard Group reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 23,254,450 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $639M.
  • Vanguard Group first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Vanguard Group's Change Healthcare Inc. Common Stock position peaked at $639M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.